For the second time in four weeks, GSK has settled a personal injury lawsuit in California state court over the heartburn drug Zantac (ranitidine). The company revealed the dismissal of the case and ...

(Reuters) - GSK agreed to confidentially settle another lawsuit in California that had alleged its discontinued heartburn drug Zantac caused cancer, the latest in a series of settlements made by the ...

(Reuters) -GSK shares jumped as much as 6.5% on Thursday after the British drugmaker struck a $2.2 billion settlement over U.S. lawsuits that alleged its discontinued heartburn drug Zantac caused ...

Sanofi stated that the settlement encompasses many pending cases across various U.S. state courts, excluding Delaware. Sanofi reintroduced Zantac without ranitidine and is now using famotidine. Get ...

Pfizer Inc. has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of its Zantac heartburn drug, according to people familiar with the deal, the biggest of the litigation.

On Wednesday, GSK plc (NYSE:GSK) reached agreements with ten plaintiff firms representing approximately 80,000 Zantac product liability cases in the U.S. state courts. These cases account for 93% of ...

Sanofi will pay more than $100 million to settle about 4,000 lawsuits accusing the French drugmaker of failing to warn users that its Zantac heartburn medicine could cause cancer, according to people ...

British pharmaceutical company GSK plc settled another lawsuit that claimed its discontinued heartburn drug Zantac can cause cancer. The company said Wednesday that it has "reached a confidential ...

After GSK spent the latter half of 2023 warding off concerns about the swelling Zantac product liability litigation, the company is back at the settlement table in 2024. Thursday, GSK said it has ...

(Reuters) -GSK said on Thursday it had agreed to settle another lawsuit in California that alleged its discontinued heartburn drug Zantac caused cancer, the latest in a series of settlements to end ...